Phase 2 Clinical Trial of GH001 in Bipolar II Disorder

Status Recruiting

Clinical Trial Summary

This study is a multicenter, open-label, single-arm Phase 2 clinical trial. Approximately 15 participants with clinically diagnosed bipolar disorder (BD) type II and experiencing a current episode of depression will be included in this study. The participants will receive an individualized dosing regimen (IDR) with at least one and up to three doses of GH001 administered within a single day.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05839509
Study type	Interventional
Source	GH Research Ireland Limited
Contact	Project Manager
Phone	+ 353 1 437 8334
Email	clinicaltrials@ghres.com
Status	Recruiting
Phase	Phase 2
Start date	April 6, 2023
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03641300` - Efficacy of Convulsive Therapies for Bipolar Depression	N/A
Recruiting	`NCT05340686` - Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression	N/A
Completed	`NCT00761761` - Sensoril(Ashwaganhda)for Bipolar Disorder	Phase 3
Active, not recruiting	`NCT04561622` - Emotional Proactive Processing in Bipolar Disorder
Completed	`NCT03334721` - Gabapentin for Bipolar & Cannabis Use Disorders	Phase 2
Active, not recruiting	`NCT05658510` - Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)	Phase 3
Not yet recruiting	`NCT06184581` - Lithium Versus Lamotrigine in Bipolar Disorder, Type II	Phase 4
Active, not recruiting	`NCT03484494` - Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression	N/A
Recruiting	`NCT05400785` - Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning	N/A
Completed	`NCT05340504` - Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder	Phase 2
Active, not recruiting	`NCT05249309` - Naturalistic Study of Ketamine in the Treatment of Depression
Recruiting	`NCT04211428` - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
Completed	`NCT03822416` - Treating Smokers With Mental Illness	Phase 2
Completed	`NCT01588457` - Sequential Multiple Assignment Treatment for Bipolar Disorder	Phase 4
Completed	`NCT03156504` - The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.	Phase 4
Recruiting	`NCT05004896` - Ketamine for Treatment-Resistant Bipolar Disorder	Phase 2
Terminated	`NCT02491307` - Ginger.io Behavioral Health Study	N/A
Recruiting	`NCT05427123` - Children's Bipolar Network Treatment Trial I
Not yet recruiting	`NCT05705063` - Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness	N/A
Recruiting	`NCT05065294` - Psilocybin Therapy for Depression in Bipolar II Disorder	Phase 2